Logo
x

Search category

Subscribe Now

Orphan drug designation

New Drug Designations - August 2023

New Drug Designations - August 2023

  • September 18, 2023
Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer

Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer

  • November 16, 2021
PharmaTher's Ketamine Receives the US FDA's Orphan Drug Designation for Complex Regional Pain Syndrome

PharmaTher's Ketamine Receives the US FDA's Orphan Drug Designation for Complex Regional Pain Syndrome

  • October 14, 2021
C4T's CFT7455 Receives the US FDA's Orphan Drug designation for the Treatment of Multiple Myeloma

C4T's CFT7455 Receives the US FDA's Orphan Drug designation for the Treatment of Multiple Myeloma

  • August 12, 2021
LEXEO Therapeutics' LX2006 Receives the US FDA's Rare Pediatric Disease Designation and Orphan Drug Designation to Treat Friedreich Ataxia

LEXEO Therapeutics' LX2006 Receives the US FDA's Rare Pediatric Disease Designation and Orphan Drug Designation to Treat Friedreic...

  • July 1, 2021
Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

  • May 28, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.